Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NIDA tests AZD-8529 for smoking cessation

July 7, 2015

Invion completes dosing in phase II trial of oral INV-102 in smoking cessation

July 1, 2015

BARDA exercises additional contract funding for AEOL-10150

July 1, 2015

NIAAA initiates trial of Horizant for alcohol use disorder

June 29, 2015

Laboratorio Farmaceutico CT patents gamma-hydroxybutyric acid prodrugs

June 22, 2015

Pre-EUA dossier for Cleveland Biolabs' entolimod submitted to FDA

June 16, 2015

Probuphine noninferior to sublingual buprenorphine in phase III trial in opioid dependence

June 9, 2015

AEOL-10150 doubles survival in primate model of radiation-induced lung injury

May 5, 2015

Adapt Pharma successfully completes pharmacokinetic study of intranasal naloxone

April 24, 2015

FDA approves filgrastim for myelosuppression in acute radiation injury

April 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...